BioSpace News Archive

Pharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

As the world continues to grapple with the effects of the COVID-19 pandemic, healthcare analysts are starting to wonder how the outbreak will impact drug development.

Sobi™ announced that the results from the pivotal phase 2/3 study evaluating the efficacy and safety of emapalumab in patients with primary haemophagocytic lymphohistiocytosis were published in the New England Journal of Medicine on 7 May 2020.

First clinical data from tiragolumab, Genentech’s novel anti-TIGIT cancer immunotherapy, in combination with Tecentriq in people with PD-L1-positive metastatic non-small cell lung cancer (NSCLC)

FDA and EMA endorse the advancement of cobitolimod into phase III studies

Rising prevalence of cancer is one the major factors driving growth of tissue diagnostic market.

Recombinase Polymerase Amplification is a new isothermal method to amplify the DNA as well as RNA.

Transparency Market Research has published a new report titled, “Pharmacy Repackaging Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

With forecasts about competition getting fiercer, companies operating in the global oncology information system market are investing in the development of technologically advanced information systems.

The global intraosseous devices market was valued at US$ 361.1 Mn in 2017 and is estimated to expand at a cumulative annual growth rate of 5.6% from 2018 to 2026 according to a new report published by Transparency Market Research titled “Intraosseous Devices Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.